Medically reviewed by Ritchie Stevens, MD, Radiation Oncologist on June 8, 2026.
_1782506263683-DvIGI5Jo.jpg)
Adaptive radiotherapy for gynecologic cancer
In the pelvis, the bladder and rectum change filling throughout the day — shifting the cervix, uterus, and nearby lymph nodes with them. Conventional radiation treats a fixed plan that cannot respond to these daily changes, exposing more bladder and bowel to therapeutic dose. Online adaptive RT on the Akesis Gemini 360 re-images the pelvis before each session and reshapes the plan around today's anatomy.
Why Gynecologic Cancer needs more than a fixed plan
Pelvic anatomy is among the most variable in the body. These three challenges explain why conventional radiation struggles to deliver precise treatment for gynecologic cancers.
Daily bladder and bowel filling variation
The cervix and uterus shift 10–30 mm depending on how full the bladder and rectum are. A plan built on one day's anatomy may be badly misaligned by the next session — treating adjacent healthy tissue rather than the tumor.
Bone marrow in the radiation field
Pelvic radiation inevitably includes pelvic bone marrow in the treatment volume. Wide margins from motion uncertainty increase the irradiated bone marrow volume, compounding hematological toxicity — particularly relevant when chemotherapy is given concurrently.
Bladder and rectal toxicity
The bladder wall and rectum are immediately adjacent to the cervix and uterus. Larger margins to account for motion uncertainty translate directly into higher doses to these structures, increasing the risk of long-term urinary and bowel side effects.
What the evidence shows
Online adaptive radiotherapy for gynecologic cancers — particularly cervical cancer — has been validated in multiple institutional studies demonstrating clear dosimetric benefits over fixed-plan IMRT.
Heijkoop et al.: plan-of-the-day reduced rectal dose by 17%
This prospective clinical trial implemented an online adaptive plan-of-the-day protocol for locally advanced cervical cancer. Compared to a fixed IMRT plan, the adaptive approach reduced rectal dose by 17% and bladder dose by 11%, without compromising target coverage — a direct translation of adaptive capability into fewer bowel and urinary side effects.
doi.org/10.1016/j.ijrobp.2014.06.046Sibolt et al.: AI-driven CBCT adaptive RT is clinically feasible
This multi-center study implemented AI-driven online adaptive radiotherapy using CBCT in the pelvic region and demonstrated consistent plan quality across patients — with mean treatment times that fit within standard clinical workflows. The study validated the clinical feasibility of the approach at scale.
doi.org/10.1016/j.phro.2020.12.004RetroEMBRACE: image-guided adaptive brachytherapy improves pelvic control and survival
The RetroEMBRACE multicenter cohort study demonstrated that image-guided adaptive brachytherapy — planned to the actual tumor volume at the time of boost — achieved significantly improved pelvic control and overall survival for locally advanced cervical cancer compared to historical outcomes. The underlying principle — adapting to current anatomy — directly extends to external beam adaptive RT in the initial treatment phase.
doi.org/10.1016/j.radonc.2016.03.011Your treatment workflow
At 5D Cancer Services, gynecologic cancer adaptive radiotherapy follows a protocol designed to minimize pelvic organ variability and protect the bladder, rectum, and bone marrow at every session.
Simulation CT with bladder preparation
A planning CT is acquired with standardized bladder filling (typically comfortably full) and rectal preparation. The radiation oncologist contours the GTV, CTV, pelvic lymphatics, bladder, rectum, sigmoid, small bowel, and bone marrow.
IMRT or VMAT treatment planning
An intensity-modulated plan is optimized to cover the cervix/uterus and nodal regions while minimizing dose to the bladder wall, rectum, sigmoid, and pelvic bone marrow. Constraints follow QUANTEC and EMBRACE guidelines.
Daily CBCT imaging and adaptation
Before each session, a CBCT is acquired. The Gemini 360 re-localizes the target and surrounding organs in today's anatomy and adapts the plan to minimize dose to the organs at risk. Each session takes approximately 30–60 minutes.
Concurrent chemotherapy and brachytherapy coordination
For locally advanced cervical cancer, weekly cisplatin chemotherapy is typically given concurrently with external beam radiation. After external beam completion, intracavitary brachytherapy delivers the final tumor-focused dose. Our team coordinates the full treatment timeline.
Adaptive vs. conventional radiation
| Factor | Adaptive RT (Gemini 360) | Conventional Radiation |
|---|---|---|
| Total sessions | 5–25 depending on stage and cancer type | 25–28 sessions over 5–6 weeks |
| Daily imaging | CBCT at every session | Periodic imaging |
| Plan adaptation | Re-optimized to today's bladder/bowel filling | Fixed plan regardless of anatomy changes |
| Rectal dose | Reduced by ~17% vs. fixed IMRT | Higher with standard margins |
| Bladder dose | Reduced by ~11% vs. fixed IMRT | Higher with standard margins |
| Bone marrow sparing | Improved with tighter margins | Limited with fixed margins |
Frequently asked questions
What types of gynecologic cancer can be treated with adaptive radiotherapy?
Adaptive radiotherapy on the Gemini 360 can treat cervical cancer, uterine (endometrial) cancer, vaginal cancer, and vulvar cancer. The adaptive benefit is greatest for cervical and uterine cancers, where daily bladder and bowel variation most significantly affects target position.
Does our team have specific experience with gynecologic cancers?
Yes. Our medical director has over 30 years of radiation oncology experience with a specific focus on gynecologic malignancies. This depth of specialization informs every aspect of treatment planning and delivery for cervical, uterine, and other pelvic cancers.
Can adaptive radiotherapy be used with chemotherapy?
Yes. For locally advanced cervical cancer, adaptive external beam radiotherapy is typically delivered concurrently with weekly cisplatin chemotherapy, following national guidelines. The adaptive approach does not interfere with concurrent systemic therapy.
What side effects should I expect from pelvic radiation?
With online adaptive radiotherapy, bladder and bowel side effects are reduced compared to conventional fixed-plan radiation. Some patients experience mild urinary frequency, loose stools, or fatigue during treatment. These symptoms are usually temporary and resolve within a few weeks after completing radiation.
Educational information — not medical advice
The content on this page is provided for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay seeking it because of something you have read on this site. If you think you may have a medical emergency, call your doctor or 911 immediately.
References
- 1.Heijkoop ST, Langerak TR, Quint S, et al. Clinical Implementation of an Online Adaptive Plan-of-the-Day Protocol for Nonrigid Motion Management in Locally Advanced Cervical Cancer IMRT. Int J Radiat Oncol Biol Phys. 2014;90(3):673–679. doi.org/10.1016/j.ijrobp.2014.06.046
- 2.Sibolt P, Andersson LM, Calmels L, et al. Clinical implementation of artificial intelligence-driven cone-beam computed tomography-guided online adaptive radiotherapy in the pelvic region. Phys Imaging Radiat Oncol. 2021;17:1–7. doi.org/10.1016/j.phro.2020.12.004
- 3.Sturdza A, Pötter R, Fokdal LU, et al. Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study. Radiother Oncol. 2016;120(3):428–433. doi.org/10.1016/j.radonc.2016.03.011
Also see: Adaptive RT by cancer type
Please do not send Protected Health Information (PHI) by email or voicemail. Standard email is not secure — call us and we will arrange a secure channel.
